首页> 美国卫生研究院文献>Clinical Endoscopy >Currently Available Non-Balloon Devices
【2h】

Currently Available Non-Balloon Devices

机译:当前可用的非气球设备

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Obesity and metabolic syndrome are known to have an impact on the economy. Obesity and metabolic syndrome affect about 40% population in the America alone, and with about 400 million obese adults in the world, obesity is a global concern. Moreover, the prevalence of overweight children is increasing. Bariatric surgery remains the gold standard for the treatment of obesity; however, endoscopic approaches may have a significant role in the management of metabolic syndrome and obesity. Until recently, many endoscopic methods have been introduced; however, few methods are used in practice, whereas others are under experimental research. Endoscopists have an important role in the treatment of obesity because endoscopic therapies have demonstrated their safety and efficacy over the past few years. Endoscopic bariatric therapies can be categorized as follows: space occupying, malabsorption, and gastric volume reduction. In this review, we summarize the currently available non-balloon type endoscopic procedure.
机译:已知肥胖和代谢综合症对经济有影响。肥胖和代谢综合症仅在美国就影响约40%的人口,并且肥胖症在世界上有约4亿成年人,肥胖是全球关注的问题。此外,超重儿童的患病率正在增加。减肥手术仍然是肥胖症治疗的金标准;然而,内镜治疗可能在代谢综合征和肥胖症的治疗中起重要作用。直到最近,已经引入了许多内窥镜检查方法。但是,实践中很少使用方法,而其他方法正在实验研究中。内镜医师在肥胖症的治疗中起着重要作用,因为内窥镜疗法在过去的几年中已证明其安全性和有效性。内窥镜减肥治疗可以归类为:占位,吸收不良和胃体积减少。在这篇综述中,我们总结了当前可用的非气球型内窥镜检查程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号